KR20040091135A - 염산 필지카이니드 함유 정제(건식) - Google Patents

염산 필지카이니드 함유 정제(건식) Download PDF

Info

Publication number
KR20040091135A
KR20040091135A KR10-2004-7014386A KR20047014386A KR20040091135A KR 20040091135 A KR20040091135 A KR 20040091135A KR 20047014386 A KR20047014386 A KR 20047014386A KR 20040091135 A KR20040091135 A KR 20040091135A
Authority
KR
South Korea
Prior art keywords
tablet
hydrochloric acid
tablets
hardness
bitter taste
Prior art date
Application number
KR10-2004-7014386A
Other languages
English (en)
Korean (ko)
Inventor
가또아쯔시
Original Assignee
다이이찌 산토리 파마 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다이이찌 산토리 파마 가부시키가이샤 filed Critical 다이이찌 산토리 파마 가부시키가이샤
Publication of KR20040091135A publication Critical patent/KR20040091135A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
KR10-2004-7014386A 2002-03-14 2003-03-13 염산 필지카이니드 함유 정제(건식) KR20040091135A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2002-00070211 2002-03-14
JP2002070211 2002-03-14
PCT/JP2003/002975 WO2003075919A1 (fr) 2002-03-14 2003-03-13 Comprime contenant du chlorhydrate de pilsicainide (voie seche)

Publications (1)

Publication Number Publication Date
KR20040091135A true KR20040091135A (ko) 2004-10-27

Family

ID=27800336

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2004-7014386A KR20040091135A (ko) 2002-03-14 2003-03-13 염산 필지카이니드 함유 정제(건식)

Country Status (4)

Country Link
JP (1) JPWO2003075919A1 (ja)
KR (1) KR20040091135A (ja)
AU (1) AU2003213338A1 (ja)
WO (1) WO2003075919A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2523158C (en) 2003-04-24 2010-11-16 Jagotec Ag Delayed release tablet with defined core geometry
DE102004043863A1 (de) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
CA2579732C (en) * 2004-09-10 2014-08-12 Nitec Pharma Ag Tablets with site time-controlled gastrointestinal release of active ingredient
PE20080180A1 (es) * 2006-05-23 2008-04-22 Takeda Pharmaceutical Preparacion oral de pioglitazona
PT2049123E (pt) 2006-08-03 2013-03-06 Horizon Pharma Ag Tratamento de doença reumatóide com glucocorticóide de libertação retardada
KR20140087846A (ko) * 2012-12-31 2014-07-09 주식회사 삼양바이오팜 테모졸로미드를 포함하는 안정성이 개선된 약제학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56156283A (en) * 1980-05-07 1981-12-02 Suntory Ltd 8-substituted pyrrolitidine and its quaternary ammonium salt
EP0722732A1 (en) * 1995-01-24 1996-07-24 Mitsui Toatsu Chemicals, Inc. Long-acting drug formulation containing pyrimidinedione derivatives
WO1998002185A1 (fr) * 1996-07-12 1998-01-22 Daiichi Pharmaceutical Co., Ltd. Materiaux moules par compression, a desagregation rapide, et leur procede de production

Also Published As

Publication number Publication date
JPWO2003075919A1 (ja) 2005-06-30
WO2003075919A1 (fr) 2003-09-18
AU2003213338A1 (en) 2003-09-22

Similar Documents

Publication Publication Date Title
RU2201216C2 (ru) Быстро расщепляющаяся фармацевтическая лекарственная форма
US6238695B1 (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
CA2453117C (en) Oral dosage forms comprising a benzimidazole and buffer
KR20040099265A (ko) 신규의 치환 벤즈이미다졸 제형 및 그 사용방법
ZA200508361B (en) Orally disintegrating tablets
JP2010090168A (ja) 医薬組成物
AU2002330863A1 (en) Novel substituted benzimidazole dosage forms and method of using same
PL200957B1 (pl) Kompozycja farmaceutyczna celecoxib'u i zastosowanie kompozycji farmaceutycznej
EP1356816A1 (en) Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient
ES2377426T3 (es) Composición de zibotentán que contiene manitol y celulosa microcristalina
CN100389751C (zh) 含扑热息痛的吞咽片剂
EP0749308B1 (en) Film coated tablet of paracetamol and domperidone
US20060240101A1 (en) Orally disintegrating pharmaceutical tablet formulations of olanzapine
JP2008285434A (ja) 口腔内速崩壊錠
WO2011102504A1 (ja) 経口用徐放性固形製剤
KR20040007665A (ko) 파라세타몰을 포함하는 연하 정제
KR20040091135A (ko) 염산 필지카이니드 함유 정제(건식)
JP2005112825A (ja) 胃内浮遊性固形製剤
AU2011379627A1 (en) Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof
PT1646373E (pt) Composição farmacêutica orodispersível de um composto antitrombótico
KR20050002856A (ko) 염산 필지카이니드 함유 정제(습식)
CN115154429A (zh) 一种他达拉非口腔崩解组合物
Magar FORMULATION AND EVALUTION OF ORAL DISPERSIBLE TABLETS
WO2023172958A1 (en) Stable formulations of talabostat
JP2002512614A (ja) 化学的かつ熱的に安定なノルアステミゾール製剤

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application